"estrogen therapy" trang 2 - tải miễn phí từ tailieunhanh
Awareness of preventive medication among women at high risk for breast cancer and their willingness to consider transdermal or oral tamoxifen: A focus group study

Awareness of preventive medication among women at high risk for breast cancer and their willingness to consider transdermal or oral tamoxifen: A focus group study
8    53    1
Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy

Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
11    59    1
Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13

Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13
12    27    1
Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer

Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
15    23    1
Case report: Anti-hormonal therapy in the treatment of ductal carcinoma of the parotid gland

Case report: Anti-hormonal therapy in the treatment of ductal carcinoma of the parotid gland
4    46    1
Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies
11    29    1
Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy

Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy
7    39    1
Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer

Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
11    35    1
A clinicopathological study and survival analysis of 99 breast cancers with HER2/ CEP17 ratio≥2.0 and an average HER2 copy number

A clinicopathological study and survival analysis of 99 breast cancers with HER2/ CEP17 ratio≥2.0 and an average HER2 copy number
13    3    1
The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer

The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
11    77    1
Impact of media compositions and culture systems on the immunophenotypes of patient-derived breast cancer cells

Impact of media compositions and culture systems on the immunophenotypes of patient-derived breast cancer cells
13    1    1